Your shopping cart is currently empty

Eledoisin (Eledone peptide) is an undecapeptide of mollusk origin in the tachykinin family of neuropeptides, serving as a specific agonist of NK2 and NK3 receptors.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $297 | 35 days | 35 days | |
| 5 mg | $1,180 | 35 days | 35 days | |
| 10 mg | $2,130 | 35 days | 35 days |
| Description | Eledoisin (Eledone peptide) is an undecapeptide of mollusk origin in the tachykinin family of neuropeptides, serving as a specific agonist of NK2 and NK3 receptors. |
| In vitro | Eledoisin increases basal activity by 24.5±3.7%; however, its stimulation is significantly reduced to 13.1±1.9% in the presence of CP99994 (P<0.01). This effect demonstrates the compound's sensitivity to CP99994, further validated through similar tests with 0.1 μM SR48968 and 0.1 μM SB222200. SR48968 significantly decreases Eledoisin's effect (P<0.01), whereas SB222200 does not alter it. This data collectively indicates that Eledoisin's stimulatory action is diminished by CP99994 and SR48968, which are NK1 and NK2 antagonists, respectively[1]. |
| In vivo | Injection of Eledoisin (0.1-1 nmol/kg) into rats produces a biphasic cardiovascular response that consists of an initial fall of systemic blood pressure (8-15 mm Hg) followed by a rise (20-22 mm Hg). |
| Synonyms | Eledone peptide |
| Molecular Weight | 1188.4 |
| Formula | C54H85N13O15S |
| Cas No. | 69-25-0 |
| Smiles | CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C1CCC(=O)N1)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(N)=O |
| Relative Density. | 1.289 g/cm3 |
| Sequence | {Glp}-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2 |
| Sequence Short | {Glp}-PSKDAFIGLM |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | H2O: 18.15 mg/mL (15.27 mM), Sonication and heating are recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
H2O
| |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.